FLNA as of Oct 30 · 22:59 ET
FLNANasdaqPharmaceutical Preparations

Filana Therapeutics, Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▼−1.73%—
quarterimplied−5%0+5%realized×
Q2 FY26—▼−1.73%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

7disclosed supplier and customer ties in SEC filingsSEC filings
84managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

12 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

FLNA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±45.2% into Nov 11 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.